Clinical Trial Update: Study of Daily Rifapentine for Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating daily rifapentine for pulmonary tuberculosis has completed; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• rifapentine (rifapentine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2016-09-28